Re:AlphaFold-Powered Drug Discovery of a Novel CDK20 Inhibitor
by RandomLensman on Tuesday January 25, 2022 @06:34AM
(#30070691)
Success rate is really low from an end-to-end perspective, but I would not call this a failure (and I expect the same from this approach). It reflects the difficulty of the task.
[ Parent
| on HN ]
There are no comments on this comment yet.